Healthcare -
Biotechnology - NASDAQ - US
$ 11.17
-1.97 %
$ 552 M
Market Cap
-3.04
P/E
KALV - OPERATING EXPENSES
Operating Expenses KALV - KalVista Pharmaceuticals, Inc.
54.3 M
LAST VALUE
-25.05%
2 YEAR CAGR
3.39%
5 YEAR CAGR
25.43%
10 YEAR CAGR